Calysta Stock

calysta.comEnergy / Clean EnergyFounded: 2011Funding to Date: $169.55MM

Calysta, founded in 2011, is the developer of sustainable food products designed to improve worldwide food security. Through their patented fermentation platform, Calysta creates products for fish and livestock, pets, and human consumption that use no arable land, plant, or animal products, and powered by renewable energy. Calysta’s family of products include FeedKind, FeedKind Net Zero, and Positive Protein.

Register To Buy and Sell Shares

For more details on financing and valuation for Calysta, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Calysta’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Calysta.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Alan Shaw Ph.D
Co-Founder, President & Chief Executive Officer
Keysha Bailey
Chief Financial Officer
Geoff Bryant
Chief Technology Officer
Lori Giver Ph.D
Chief Science & Sustainability Officer
Graham Aylen
Global Vice President, Capital Projects

Board Members

Daniela Proske Ph.D
BP Ventures
Suan Tan
Temasek Holdings

Frequently Asked Questions About Calysta’s Stock

Can you buy Calysta’s stock?
Calysta is not publicly traded on NYSE or NASDAQ in the U.S. To buy Calysta’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Calysta’s stock?
Yes, you can sell stock of a private company like Calysta. Forge can help you sell your Calysta stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Calysta’s stock price?
Calysta is a privately held company and therefore does not have a public stock price. However, you may access Calysta’s private market stock price with Forge Data.
What is Calysta’s stock ticker symbol?
Calysta does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

FeedKind® Protein Wins FDA GRAS Status for Use in Aquaculture
Calysta, the world leader in fermented protein, has announced that its leading product, FeedKind®, has achieved generally recognized as safe (GRAS) status with the United States Food and Drug Administration (FDA). The FDA’s Center for Veterinary Medicine have granted Calysta’s FeedKind protein GRAS status for use in the US in salmonid feeds at up to 18% of the diet. In the US FeedKind will be listed under its common name, dried fermentation biomass.
New Era of Food Security Beckons as World’s First Industrial-scale Alternative Protein Facility Switches On
The world’s first industrial-scale facility to produce FeedKind®, a protein ingredient that needs no animal or plant matter to produce, has been switched on by Calysseo. Calysseo, a joint venture between worldwide animal nutrition leader Adisseo and protein innovator Calysta, will initially produce 20,000 tonnes of protein per year from the facility in Chongqing, China. With startup operations complete, the fermenter will become world’s largest single protein production facility.
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.